HEDS Reference Set Application: Amit Singal, UTSW (2021) Prognostic Liver Secretome signature Validation

Abbreviated Name
HEDS Ref Set App: Singal (2021) PLSec
Lead Investigator
Singal, AmitUT Southwestern Medical Center
Coordinating Investigator
Feng, Ziding Fred Hutchinson Cancer Center
Involved Investigators


see objectives


To validate the performance of a blood-based molecular signature, Prognostic Liver Secretome signature (PLSec), to predict long-term risk of developing HCC in cirrhosis patients.

Analytic Method

Biomarker will be run blinded to clinical outcome


Validate predictive biomarker for development of HCC in patients with cirrhosis


  • No publications available at this time for this protocol.


  • No biomarkers available at this time for this protocol.

Data Collections

  • No data collections available at this time for this protocol.
 Team Project
Start Date
May 1 2021
Estimated Finish Date
Feb 1 2022
Finish Date
Nov 17 2021
Protocol ID
Protocol Type
Reference Set
Fields of Research
  • Proteomics
Collaborative Group
G.I. and Other Associated Cancers Research Group
Cancer Types
  • Liver cell carcinoma

Associated Forms